Case File №
#VI-2026-0131
Lisa Biopeptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
34 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 11 | 8.0 | 6.0 | 9.4 | 13 Dec 2025 |
| 5-amino-1MQ | X N/A | 1 | 7.5 | 7.5 | 7.5 | 28 Mar 2025 |
| AICAR | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 |
| BPC-157 Capsule | X N/A | 1 | 7.9 | 7.9 | 7.9 | 27 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| Chonluten | X N/A | 1 | 9.5 | 9.5 | 9.5 | 16 Mar 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 8.5 | 8.5 | 8.5 | 24 Apr 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 9.1 | 9.1 | 9.1 | 14 Jan 2025 |
| Dianabol | X N/A | 1 | 9.5 | 9.5 | 9.5 | 27 Feb 2025 |
| DSIP | X N/A | 1 | 7.9 | 7.9 | 7.9 | 24 Apr 2025 |
| EPO | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 |
| GHRP-2 Acetate | X N/A | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 |
| GHRP-6 Acetate | X N/A | 1 | 6.1 | 6.1 | 6.1 | 24 Apr 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 6.0 | 6.0 | 6.0 | 16 Mar 2025 |
| IGF-1 LR3 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 11 Jun 2025 |
| Lipo-B 216mg | X N/A | 1 | 7.5 | 7.5 | 7.5 | 21 May 2025 |
| Liraglutide | X N/A | 1 | 6.2 | 6.2 | 6.2 | 2 Jul 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.2 | 8.2 | 8.2 | 3 Jul 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 3 Jul 2025 |
| NAD+ | X N/A | 1 | 9.7 | 9.7 | 9.7 | 13 Feb 2025 |
| Nitroethane CAS 79-24-3 | X N/A | 1 | 7.9 | 7.9 | 7.9 | 28 Mar 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 |
| Primobolan E | X N/A | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 9.5 | 9.5 | 9.5 | 25 Apr 2025 |
| Selank | X N/A | 1 | 6.8 | 6.8 | 6.8 | 8 Jul 2025 |
| SNAP-8 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 9.2 | 9.2 | 9.2 | 2 Jul 2025 |
| Test Suspension | X N/A | 1 | 7.8 | 7.8 | 7.8 | 9 Jun 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 |
| Testosterone Phenylpropionate Raw | X N/A | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 |
| Thymalin | X N/A | 1 | 6.3 | 6.3 | 6.3 | 2 Jul 2025 |
| TriTren 225 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 2 Jul 2025 |
Exhibit II
Evidence Log
40 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | DHB (1-Test Cyp) Oral | 9.4 A | 10mg | 9.2mg | -8.1% | 96.92% | mcmjm2 | Lab G | Public |
| 24 May 2026 | Tamoxifen (Nolvadex) | 10.0 A | 100mg | 101.7mg | +1.7% | 99.98% | cn3i9i | Lab B | Public |
| 24 May 2026 | AICAR | 5.3 B | 10mg | 8.5mg | -14.6% | 97.12% | g70bn0 | Lab F | Public |
| 24 May 2026 | Chonluten | 10.0 A | 2mg | 1.8mg | -7.9% | 98.03% | 22raxr | Lab E | Community |
| 24 May 2026 | Dianabol | 8.8 A | 100mg | 94.4mg | -5.6% | 98.58% | cjwm73 | Lab A | Community |
| 24 May 2026 | NAD+ | 10.0 A | 5mg | 5.8mg | +16.0% | 99.17% | tdznev | Lab B | Community |
| 24 May 2026 | Proviron (Mesterolone) | 10.0 A | 50mg | 54.5mg | +8.9% | 99.03% | t2i5gb | Lab C | Community |
| 24 May 2026 | Retatrutide | 8.9 A | 30mg | 32.4mg | +8.0% | 99.85% | 02/2026 | Lab E | Public |
| 24 May 2026 | EPO | 9.8 A | 2mg | 2.2mg | +8.6% | 97.24% | petvrw | Lab F | Public |
| 24 May 2026 | Retatrutide | 7.8 A | 10mg | 9.9mg | -1.0% | 99.80% | (no batch ID) | Lab G | Public |
| 23 May 2026 | Thymalin | 6.1 A | 20mg | 23.8mg | +18.8% | 96.45% | 5vf3h7 | Lab A | Community |
| 21 May 2026 | BPC-157 Capsule | 8.1 A | 20mg | 18.5mg | -7.7% | 97.07% | qmymvj | Lab D | Public |
| 21 May 2026 | Lipo-B 216mg | 8.3 A | 300mg/ml | 347.3mg/ml | +15.8% | 99.58% | i98alx | Lab G | Community |
| 19 May 2026 | Retatrutide | 6.0 B | 10mg | 11.2mg | +12.0% | 99.90% | (no batch ID) | Lab E | Public |
| 19 May 2026 | Retatrutide | 8.0 A | 10mg | 10mg | 99.90% | (no batch ID) | Lab E | Public | |
| 19 May 2026 | Retatrutide | 8.0 A | 60mg | 62.7mg | +4.5% | 99.90% | (no batch ID) | Lab G | Public |
| 19 May 2026 | Ostarine (MK-2866) | 6.0 A | 50mg | 48.8mg | -2.5% | 95.71% | jy68zs | Lab E | Community |
| 17 May 2026 | 5-amino-1MQ | 7.2 A | 30mg | 36.3mg | +21.0% | 97.75% | 0x9tpm | Lab D | Community |
| 17 May 2026 | Nitroethane CAS 79-24-3 | 9.4 A | 500g | 571.8g | +14.4% | 97.71% | 2of0x2 | Lab D | Public |
| 17 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 7.7 A | 300mg/ml | 362.3mg/ml | +20.8% | 96.25% | 34mhr9 | Lab B | Public |
| 29 Jan 2026 | Retatrutide | 6.6 B | 10mg | 10.2mg | +2.0% | 99.32% | (no batch ID) | Lab E | Public |
| 29 Jan 2026 | TriTren 225 | 7.9 A | 200mg/ml | 193.8mg/ml | -3.1% | 98.91% | 2fhl3d | Lab E | Public |
| 26 Jan 2026 | Retatrutide | 7.8 A | 20mg | 20.4mg | +2.0% | 99.80% | (no batch ID) | Lab E | Public |
| 26 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 10.0 A | 2mg | 2.3mg | +14.9% | 98.49% | dnboch | Lab D | Public |
| 26 Jan 2026 | GHRP-6 Acetate | 8.5 A | 20mg | 21.5mg | +7.4% | 97.16% | iu5j40 | Lab G | Community |
| 26 Jan 2026 | Testosterone Phenylpropionate Raw | 7.2 A | 1g | 1.2g | +16.5% | 95.79% | uaoom9 | Lab C | Public |
| 9 Jan 2026 | DSIP | 7.0 A | 2mg | 1.8mg | -8.8% | 97.05% | ewohgt | Lab A | Public |
| 7 Jan 2026 | Liraglutide | 4.9 C | 20mg | 19.3mg | -3.5% | 99.90% | 435mvz | Lab B | Public |
| 7 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.3 A | 10mg | 9.4mg | -5.6% | 99.98% | 4lkeba | Lab G | Community |
| 7 Jan 2026 | Primobolan E | 5.0 B | 100mg/ml | 102.5mg/ml | +2.5% | 96.41% | gsl5t7 | Lab G | Public |
| 7 Jan 2026 | Testosterone Decanoate Raw | 5.7 B | 1g | 1.1g | +11.7% | 99.64% | mgszl9 | Lab F | Public |
| 6 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.2 B | 15mg | 15.3mg | +1.7% | 98.03% | dul9kx | Lab A | Community |
| 29 Dec 2025 | Test Suspension | 8.4 A | 200mg/ml | 222.2mg/ml | +11.1% | 95.65% | cd85c2 | Lab E | Public |
| 12 Dec 2025 | IGF-1 LR3 | 9.4 A | 2mg | 2.0mg | -1.6% | 98.91% | 4rd372 | Lab F | Public |
| 5 Dec 2025 | N-Acetyl Epitalon Amidate | 6.0 A | 5mg | 4.3mg | -14.2% | 97.92% | 33qm5p | Lab B | Community |
| 5 Dec 2025 | Primobolan Oral (Methenolone Acetate) | 7.9 A | 20mg | 23.1mg | +15.3% | 99.81% | nj7223 | Lab C | Public |
| 17 Oct 2025 | Selank | 6.0 A | 2mg | 2.3mg | +12.9% | 96.21% | ysstd0 | Lab F | Public |
| 3 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 7.3 A | 10mg | 9.3mg | -6.6% | 96.88% | 4tektp | Lab C | Public |
| 3 Oct 2025 | GHRP-2 Acetate | 9.0 A | 15mg | 12.8mg | -14.5% | 95.73% | flvhpj | Lab G | Public |
| 3 Oct 2025 | SNAP-8 | 6.1 A | 5mg | 5.7mg | +14.2% | 95.48% | n9t814 | Lab F | Public |
— END OF EVIDENCE LOG —